Global phosphoproteomic profiling reveals distinct signatures in B-cell non-hodgkin lymphomas

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1331-1342

  Rolland, Delphine ^a   Basrur, Venkatesha ^a   Conlon, Kevin ^a   Wolfe, Thomas ^a   Fermin, Damian ^a   Nesvizhskii, Alexey I ^a   Lim, Megan S ^a   Elenitoba Johnson, Kojo S J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; B LYMPHOCYTE RECEPTOR; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 11A; EPHRIN RECEPTOR A7; JANUS KINASE 3; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID ENRICHED MICRODOMAIN 1; PROTEIN CDC42; PROTEIN KINASE LCK; PROTEIN KINASE LYN; PROTEIN KINASE SYK; PROTEIN KINASE TYK2; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; LYN PROTEIN-TYROSINE KINASE; MEMBRANE PROTEIN; PAG1 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR ANTIGEN;

ARTICLE; B CELL NON HODGKIN LYMPHOMA; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GERMINAL CENTER; IMMUNOSTIMULATION; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; BIOLOGICAL MODEL; CLUSTER ANALYSIS; GENE SILENCING; HUMAN; IMMUNOLOGY; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROCEDURES; PROTEOMICS; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; GENE KNOCKDOWN TECHNIQUES; GERMINAL CENTER; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84899524886     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.036     Document Type: Article

References (55)

1. T. Hunter Signaling-2000 and beyond Cell 100 2000 113 127
2. J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 103 2000 211 225
3. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365
4. H.C. Harsha, and A. Pandey Phosphoproteomics in cancer Mol Oncol 4 2010 482 495
5. C.G. Azzoli, S. Baker Jr., S. Temin, W. Pao, T. Aliff, J. Brahmer, D.H. Johnson, J.L. Laskin, G. Masters, D. Milton, L. Nordquist, D.G. Pfister, S. Piantadosi, J.H. Schiller, R. Smith, T.J. Smith, J.R. Strawn, D. Trent, and G. Giaccone American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer J Clin Oncol 27 2009 6251 6266
6. B.J. Druker, F. Guilhot, S.G. O'Brien, I. Gathmann, H. Kantarjian, N. Gattermann, M.W. Deininger, R.T. Silver, J.M. Goldman, R.M. Stone, F. Cervantes, A. Hochhaus, B.L. Powell, J.L. Gabrilove, P. Rousselot, J. Reiffers, J.J. Cornelissen, T. Hughes, H. Agis, T. Fischer, G. Verhoef, J. Shepherd, G. Saglio, A. Gratwohl, J.L. Nielsen, J.P. Radich, B. Simonsson, K. Taylor, M. Baccarani, C. So, L. Letvak, and R.A. Larson Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2006 2408 2417
7. C.D. Blanke, C. Rankin, G.D. Demetri, C.W. Ryan, M. von Mehren, R.S. Benjamin, A.K. Raymond, V.H. Bramwell, L.H. Baker, R.G. Maki, M. Tanaka, J.R. Hecht, M.C. Heinrich, C.D. Fletcher, J.J. Crowley, and E.C. Borden Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 J Clin Oncol 26 2008 626 632
8. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, and J.W. Vardiman WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues 2008 IARC Lyon
9. G. Lenz, G.W. Wright, N.C. Emre, H. Kohlhammer, S.S. Dave, R.E. Davis, S. Carty, L.T. Lam, A.L. Shaffer, W. Xiao, J. Powell, A. Rosenwald, G. Ott, H.K. Muller-Hermelink, R.D. Gascoyne, J.M. Connors, E. Campo, E.S. Jaffe, J. Delabie, E.B. Smeland, L.M. Rimsza, R.I. Fisher, D.D. Weisenburger, W.C. Chan, and L.M. Staudt Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways Proc Natl Acad Sci U S A 105 2008 13520 13525
10. P. De Paepe, M. Baens, H. van Krieken, B. Verhasselt, M. Stul, A. Simons, B. Poppe, G. Laureys, P. Brons, P. Vandenberghe, F. Speleman, M. Praet, C. De Wolf-Peeters, P. Marynen, and I. Wlodarska ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma Blood 102 2003 2638 2641
11. A. Rosenwald, A.A. Alizadeh, G. Widhopf, R. Simon, R.E. Davis, X. Yu, L. Yang, O.K. Pickeral, L.Z. Rassenti, J. Powell, D. Botstein, J.C. Byrd, M.R. Grever, B.D. Cheson, N. Chiorazzi, W.H. Wilson, T.J. Kipps, P.O. Brown, and L.M. Staudt Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia J Exp Med 194 2001 1639 1647
12. B. Macek, M. Mann, and J.V. Olsen Global and site-specific quantitative phosphoproteomics: principles and applications Annu Rev Pharmacol Toxicol 49 2009 199 221
13. M.R. Larsen, T.E. Thingholm, O.N. Jensen, P. Roepstorff, and T.J. Jorgensen Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns Mol Cell Proteomics 4 2005 873 886
14. J. Rush, A. Moritz, K.A. Lee, A. Guo, V.L. Goss, E.J. Spek, H. Zhang, X.M. Zha, R.D. Polakiewicz, and M.J. Comb Immunoaffinity profiling of tyrosine phosphorylation in cancer cells Nat Biotechnol 23 2005 94 101
15. K. Rikova, A. Guo, Q. Zeng, A. Possemato, J. Yu, H. Haack, J. Nardone, K. Lee, C. Reeves, Y. Li, Y. Hu, Z. Tan, M. Stokes, L. Sullivan, J. Mitchell, R. Wetzel, J. Macneill, J.M. Ren, J. Yuan, C.E. Bakalarski, J. Villen, J.M. Kornhauser, B. Smith, D. Li, X. Zhou, S.P. Gygi, T.L. Gu, R.D. Polakiewicz, J. Rush, and M.J. Comb Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 131 2007 1190 1203
16. D. Kessner, M. Chambers, R. Burke, D. Agus, and P. Mallick ProteoWizard: open source software for rapid proteomics tools development Bioinformatics 24 2008 2534 2536
17. D. Fenyo, and R.C. Beavis A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes Anal Chem 75 2003 768 774
18. B. MacLean, J.K. Eng, R.C. Beavis, and M. McIntosh General framework for developing and evaluating database scoring algorithms using the TANDEM search engine Bioinformatics 22 2006 2830 2832
19. A. Keller, A.I. Nesvizhskii, E. Kolker, and R. Aebersold Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 74 2002 5383 5392
20. A.I. Nesvizhskii, A. Keller, E. Kolker, and R. Aebersold A statistical model for identifying proteins by tandem mass spectrometry Anal Chem 75 2003 4646 4658
21. P.G. Pedrioli Trans-proteomic pipeline: a pipeline for proteomic analysis Methods Mol Biol 604 2010 213 238
22. D. Fermin, V. Basrur, A.K. Yocum, and A.I. Nesvizhskii Abacus: a computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis Proteomics 11 2011 1340 1345
23. S.A. Beausoleil, J. Villen, S.A. Gerber, J. Rush, and S.P. Gygi A probability-based approach for high-throughput protein phosphorylation analysis and site localization Nat Biotechnol 24 2006 1285 1292
24. J. Villen, S.A. Beausoleil, S.A. Gerber, and S.P. Gygi Large-scale phosphorylation analysis of mouse liver Proc Natl Acad Sci U S A 104 2007 1488 1493
25. D. Schwartz, M.F. Chou, and G.M. Church Predicting protein post-translational modifications using meta-analysis of proteome scale data sets Mol Cell Proteomics 8 2009 365 379
26. R. Suzuki, and H. Shimodaira Pvclust: an R package for assessing the uncertainty in hierarchical clustering Bioinformatics 22 2006 1540 1542
27. J.A. Vizcaino, R.G. Cote, A. Csordas, J.A. Dianes, A. Fabregat, J.M. Foster, J. Griss, E. Alpi, M. Birim, J. Contell, G. O'Kelly, A. Schoenegger, D. Ovelleiro, Y. Perez-Riverol, F. Reisinger, D. Rios, R. Wang, and H. Hermjakob The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013 Nucleic Acids Res 41 2013 D1063 D1069
28. J. Kim, D.W. Kim, W. Chang, J. Choe, C.S. Park, K. Song, and I. Lee Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt/Ca2+/NFAT/NF-kappaB-B cell lymphoma 6 signaling J Immunol 188 2012 182 189
29. P.R. Wilker, M. Kohyama, M.M. Sandau, J.C. Albring, O. Nakagawa, J.J. Schwarz, and K.M. Murphy Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation Nat Immunol 9 2008 603 612
30. C.P. Bracken, S.J. Wall, B. Barre, K.I. Panov, P.M. Ajuh, and N.D. Perkins Regulation of cyclin D1 RNA stability by SNIP1 Cancer Res 68 2008 7621 7628
31. T. Bruno, R. De Angelis, F. De Nicola, C. Barbato, M. Di Padova, N. Corbi, V. Libri, B. Benassi, E. Mattei, A. Chersi, S. Soddu, A. Floridi, C. Passananti, and M. Fanciulli Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb Cancer Cell 2 2002 387 399
32. D. Szklarczyk, A. Franceschini, M. Kuhn, M. Simonovic, A. Roth, P. Minguez, T. Doerks, M. Stark, J. Muller, P. Bork, L.J. Jensen, and C. von Mering The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Res 39 2011 D561 D568
33. W. Huang da, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
34. W. Huang da, B.T. Sherman, and R.A. Lempicki Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res 37 2009 1 13
35. S. Takeuchi, Y. Takayama, A. Ogawa, K. Tamura, and M. Okada Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk J Biol Chem 275 2000 29183 29186
36. T. Brdicka, D. Pavlistova, A. Leo, E. Bruyns, V. Korinek, P. Angelisova, J. Scherer, A. Shevchenko, I. Hilgert, J. Cerny, K. Drbal, Y. Kuramitsu, B. Kornacker, V. Horejsi, and B. Schraven Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation J Exp Med 191 2000 1591 1604
37. P. Casado, M.P. Alcolea, F. Iorio, J.C. Rodriguez-Prados, B. Vanhaesebroeck, J. Saez-Rodriguez, S. Joel, and P.R. Cutillas Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors Genome Biol 14 2013 R37
38. T.W. LeBien, and T.F. Tedder B lymphocytes: how they develop and function Blood 112 2008 1570 1580
39. R. Kuppers Mechanisms of B-cell lymphoma pathogenesis Nat Rev Cancer 5 2005 251 262
40. A. Wiestner, M. Tehrani, M. Chiorazzi, G. Wright, F. Gibellini, K. Nakayama, H. Liu, A. Rosenwald, H.K. Muller-Hermelink, G. Ott, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J. Vose, J.O. Armitage, R.D. Gascoyne, J.M. Connors, E. Campo, E. Montserrat, F. Bosch, E.B. Smeland, S. Kvaloy, H. Holte, J. Delabie, R.I. Fisher, T.M. Grogan, T.P. Miller, W.H. Wilson, E.S. Jaffe, and L.M. Staudt Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival Blood 109 2007 4599 4606
41. J. Camps, I. Salaverria, M.J. Garcia, E. Prat, S. Bea, J.C. Pole, L. Hernandez, J. Del Rey, J.C. Cigudosa, M. Bernues, C. Caldas, D. Colomer, R. Miro, and E. Campo Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines Leuk Res 30 2006 923 934
42. R. M'Kacher, F. Farace, A. Bennaceur-Griscelli, D. Violot, B. Clausse, J. Dossou, A. Valent, C. Parmentier, V. Ribrag, J. Bosq, P. Carde, A.G. Turhan, and A. Bernheim Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model Cancer Genet Cytogenet 143 2003 32 38
43. R.E. Davis, V.N. Ngo, G. Lenz, P. Tolar, R.M. Young, and P.B. Romesser et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma Nature 463 2010 88 92
44. L.A. Honigberg, A.M. Smith, M. Sirisawad, E. Verner, D. Loury, B. Chang, S. Li, Z. Pan, D.H. Thamm, R.A. Miller, and J.J. Buggy The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy Proc Natl Acad Sci U S A 107 2010 13075 13080
45. A. Flemming Target discovery: blocking BTK in B-cell disorders Nat Rev Drug Discov 9 2010 681
46. S. Cheng, G. Coffey, X.H. Zhang, R. Shaknovich, Z. Song, P. Lu, A. Pandey, A.M. Melnick, U. Sinha, and Y.L. Wang SYK inhibition and response prediction in diffuse large B-cell lymphoma Blood 118 2011 6342 6352
47. T. Kanou, C. Oneyama, K. Kawahara, A. Okimura, M. Ohta, N. Ikeda, Y. Shintani, M. Okumura, and M. Okada The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation Mol Cancer Res 9 2011 103 114
48. A. Sirvent, C. Benistant, J. Pannequin, L. Veracini, V. Simon, J.F. Bourgaux, F. Hollande, F. Cruzalegui, and S. Roche Src family tyrosine kinases: driven colon cancer cell invasion is induced by Csk membrane delocalization Oncogene 29 2010 1303 1315
49. C. Oneyama, T. Hikita, K. Enya, M.W. Dobenecker, K. Saito, S. Nada, A. Tarakhovsky, and M. Okada The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src Mol Cell 30 2008 426 436
50. E. Janssen, and W. Zhang Adaptor proteins in lymphocyte activation Curr Opin Immunol 15 2003 269 276
51. M. Smida, A. Posevitz-Fejfar, V. Horejsi, B. Schraven, and J.A. Lindquist A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation Blood 110 2007 596 615
52. M. Kawabuchi, Y. Satomi, T. Takao, Y. Shimonishi, S. Nada, K. Nagai, A. Tarakhovsky, and M. Okada Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases Nature 404 2000 999 1003
53. A. Svec, Z. Velenska, and V. Horejsi Expression pattern of adaptor protein PAG: correlation between secondary lymphatic follicle and histogenetically related malignant lymphomas Immunol Lett 100 2005 94 97
54. A. Svec Expression of transmembrane adaptor protein PAG/Cbp in diffuse large B-cell lymphoma: immunohistochemical study of 73 cases Pathol Res Pract 203 2007 193 198
55. S.A. Solheim, E. Petsalaki, A.J. Stokka, R.B. Russell, K. Tasken, and T. Berge Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity FEBS J 275 2008 4863 4874